All non-company consultees have 8 weeks to submit a statement on the potential clinical and cost effectiveness of a treatment. We ask the intervention technology company to produce a submission of all ...

A recent survey found that 82% of pharmaceutical industry professionals believe that digital transformation will either significantly or moderately shorten the drug development timeline.